扁平苔藓与苔藓样皮肤病:传统与新兴治疗策略
本文是两篇系列继续医学教育文章的第二篇,在回顾苔藓样皮肤病临床亚型及分子基础后,讨论常见苔藓样炎症的现有与新兴治疗策略,概述其药效动力学与证据基础,并将疾病机制与药物作用机制相联系,同时讨论未来转化研究方向。
要点
- 本文聚焦扁平苔藓常见亚型的治疗策略,而非涵盖所有苔藓样变异的治疗。
- 文章概述现有与新兴治疗方案的药效动力学及证据基础。
- 重点将疾病机制与药物作用机制相联系,并讨论未来转化研究方向。
核心结论
- 本文讨论扁平苔藓与苔藓样皮肤病常见临床形式的现有与新兴治疗策略,并概述其药效动力学与证据基础。
研究设计与样本
- 本文为两篇系列继续医学教育文章的第二篇,属综述性文章,聚焦扁平苔藓常见亚型的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Having reviewed the diverse clinical subtypes of lichenoid disease and the postulated molecular basis thereof in the first article in this 2-part continuing medical education series, we discuss herein the existing and emerging treatment strategies in the most common clinical forms of lichenoid inflammation and provide an overview of their pharmacodynamics and evidence base. The scope of this review is not to exhaustively discuss treatment modalities for all lichenoid variants discussed in the previous article of this series. Instead, the focus will be on frequently encountered subtypes of lichen planus and on linking mechanisms of disease with mechanisms of drug action. Future directions and potential avenues for translational research will also be discussed.
引用
- Tziotzios C, Brier T, Lee JYW, et al. Lichen planus and lichenoid dermatoses: Conventional and emerging therapeutic strategies. J Am Acad Dermatol. 2018. PMID: 30318137. doi:10.1016/j.jaad.2018.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。